TrialHaematologica2013

Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial.

Vaishali Sanchorawala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.